Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引：0
作者：
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：37
相关论文
共 50 条
[31]   Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer [J].
Hu, Chuling ;
Liu, Yan ;
Cao, Wei ;
Li, Na ;
Gao, Shen ;
Wang, Zhuo ;
Gu, Fenfen .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 :507-526
[32]   Elucidating the Anticancer Mechanism of Arachidin-1 in Triple-Negative Breast Cancer Cells [J].
Weaver, Alexx P. ;
Mohammadhosseinpour, Sepideh ;
Medina-Bolivar, Fabricio .
FASEB JOURNAL, 2022, 36
[33]   Advanced Triple-Negative Breast Cancer [J].
Patel, Grisma ;
Prince, Alison ;
Harries, Mark .
SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
[34]   Theranostics for Triple-Negative Breast Cancer [J].
Choi, Hyeryeon ;
Kim, Kwangsoon .
DIAGNOSTICS, 2023, 13 (02)
[35]   What is triple-negative breast cancer? [J].
Irvin, William J., Jr. ;
Carey, Lisa A. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) :2799-2805
[36]   Immunotherapy in Triple-Negative Breast Cancer [J].
Emens, Leisha A. .
CANCER JOURNAL, 2021, 27 (01) :59-66
[37]   Pembrolizumab in Triple-Negative Breast Cancer [J].
Sun, Ryan ;
Wei, Lee-Jen .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15) :1435-1435
[38]   A Review of Triple-Negative Breast Cancer [J].
Ismail-Khan, Roohi ;
Bui, Marilyn M. .
CANCER CONTROL, 2010, 17 (03) :173-176
[39]   Triple-negative breast cancer: an update [J].
Boolbol, Susan K. ;
Cate, Sarah P. .
BREAST CANCER MANAGEMENT, 2014, 3 (02) :127-129
[40]   Morphotypes of the triple-negative breast cancer [J].
Koleckova, M. ;
Kolar, Z. ;
Ehrmann, J. ;
Korinkova, G. ;
Trojanec, R. .
VIRCHOWS ARCHIV, 2017, 471 :S296-S296
12345